A detailed history of First Premier Bank transactions in Exact Sciences Corp stock. As of the latest transaction made, First Premier Bank holds 300 shares of EXAS stock, worth $19,926. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$19,926
Previous $21,000 38.1%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022

SELL
$57.56 - $82.54 $978 - $1,403
-17 Reduced 5.36%
300 $21,000
Q1 2021

Apr 12, 2021

BUY
$116.57 - $155.01 $36,952 - $49,138
317 New
317 $42,000
Q3 2020

Oct 06, 2020

SELL
$72.92 - $102.01 $4,010 - $5,610
-55 Closed
0 $0
Q2 2020

Jul 07, 2020

BUY
$55.75 - $92.75 $3,066 - $5,101
55 New
55 $5,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.8B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track First Premier Bank Portfolio

Follow First Premier Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Premier Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Premier Bank with notifications on news.